Nevirapine
Product Images NDC 53104-0166

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nevirapine (NDC 53104-0166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 01

A mathematical formula displaying the Mosteller formula for calculating Body Surface Area (BSA) in square meters. It shows BSA as the square root of the product of height in centimeters and weight in kilograms, divided by 3600.*

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 02

Chemical structure of the active ingredient nevirapine, showing its molecular framework with nitrogen-containing rings and associated functional groups.*

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 03

Packaging label for Nevirapine Tablets USP 200 mg by Cipla Ltd. The label indicates a package of 60 tablets with prescription-only status. It includes storage instructions, safety warnings, and a note for pharmacists to provide a medication guide upon dispensing. The label also shows the manufacturer information located in Goa, India, and a barcode.*

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 04

Packaging label for Nevirapine Tablets USP 200 mg by Cipla Ltd. The label indicates a bottle containing 60 tablets. It includes warnings about safety seal integrity, storage conditions at 20°-25°C, and keeping out of reach of children. The label features the Cipla logo and a barcode, with the manufacturer address in Goa, India.*

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 05

Nevirapine Tablets USP 200 mg label from Cipla Ltd. The label indicates the product contains 1000 tablets with nevirapine USP as the active ingredient. It includes dosage storage instructions, safety warnings, and a barcode. The label also mentions batch overprinting information and the manufacturer's address in Goa, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.